Transform Wealth LLC Boosts Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Transform Wealth LLC grew its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 63.9% in the fourth quarter, Holdings Channel reports. The institutional investor owned 8,205 shares of the medical equipment provider’s stock after purchasing an additional 3,199 shares during the period. Transform Wealth LLC’s holdings in Intuitive Surgical were worth $4,283,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in the business. Godsey & Gibb Inc. boosted its holdings in Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 35 shares in the last quarter. MidAtlantic Capital Management Inc. acquired a new position in shares of Intuitive Surgical in the 3rd quarter valued at $33,000. Decker Retirement Planning Inc. purchased a new position in shares of Intuitive Surgical in the 4th quarter valued at $36,000. Capital Performance Advisors LLP acquired a new stake in Intuitive Surgical during the 3rd quarter worth $38,000. Finally, DT Investment Partners LLC lifted its position in Intuitive Surgical by 80.0% in the third quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock valued at $40,000 after acquiring an additional 36 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Trading Up 1.5 %

Shares of Intuitive Surgical stock opened at $592.64 on Tuesday. The company has a 50-day moving average of $541.80 and a two-hundred day moving average of $500.76. Intuitive Surgical, Inc. has a 12-month low of $362.14 and a 12-month high of $597.68. The stock has a market cap of $211.09 billion, a PE ratio of 95.28, a price-to-earnings-growth ratio of 5.04 and a beta of 1.39.

Insider Buying and Selling

In related news, insider Jamie Samath sold 22,903 shares of the business’s stock in a transaction dated Friday, November 8th. The shares were sold at an average price of $525.00, for a total value of $12,024,075.00. Following the sale, the insider now directly owns 8,757 shares in the company, valued at $4,597,425. The trade was a 72.34 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Robert Desantis sold 1,012 shares of the firm’s stock in a transaction dated Friday, October 25th. The shares were sold at an average price of $514.00, for a total transaction of $520,168.00. Following the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,830,084. This trade represents a 15.53 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 43,509 shares of company stock worth $22,602,212 in the last quarter. Company insiders own 0.80% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have issued reports on ISRG. Stifel Nicolaus raised their price objective on Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a report on Thursday, December 5th. Oppenheimer restated a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Raymond James lifted their price target on Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a research report on Monday, October 14th. Leerink Partners increased their price objective on Intuitive Surgical from $489.00 to $502.00 in a report on Thursday, October 17th. Finally, Truist Financial lifted their target price on shares of Intuitive Surgical from $570.00 to $640.00 and gave the company a “buy” rating in a report on Wednesday, December 18th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average target price of $554.17.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.